Dietary metabolism is increasingly implicated in the regulation of cardiovascular disease
and there is intense focus on understanding this relationship. The bacterial flora, which …

An increasing amount of evidence reveals that the gut microbiota is involved in the
pathogenesis and progression of various cardiovascular diseases. In patients with heart …

ABSTRACT Trimethylamine-N-oxide (TMAO) is an end-product of gut microbiome
metabolism linked to cardiovascular disease (CVD). However, precise cardiovascular …

There is increasing appreciation that changes in microbiome composition and function can
promote long-term susceptibility for cardiometabolic risk. Gut microbe-derived metabolites …

Aim: Trimethylamine N-oxide (TMAO) is a gut microbiota-derived metabolite synthesized in
host organisms from specific food constituents, such as choline, carnitine and betaine …

Advances in our understanding of how the gut microbiota contributes to human health and
diseases have expanded our insight into how microbial composition and function affect the …

Although traditional cardiovascular risk factors are well established and understood,
mortality and morbidity in patients with cardiovascular disease (CVD) remains high …

Given the prevalence of cardiovascular diseases (CVDs), as one of the most important non-
communicable diseases (NCDs), the recognition of diagnostic biomarkers and potential …

Atherosclerosis (AS) is the common pathological underpinning of numerous cardiovascular
illnesses (CVDs), and it is the leading cause of death worldwide. In recent years …

The last decade is marked by the significant reinterpretation of the gut microbiota
contribution to chronic disease progression. The researchers' careful attention is focused on …